Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.19.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period at Dec. 31, 2017 $ 562,477 $ 33 $ (71,889) $ 565,627 $ (1,869) $ 70,575
Beginning balance, shares issued (shares) at Dec. 31, 2017   33,083,133        
Beginning balance, treasury stock (shares) at Dec. 31, 2017     (651,506)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2017   32,431,627        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised 570     570    
Stock options exercised (shares)   25,750        
Restricted stock awards, net of forfeitures 0          
Restricted stock awards, net of forfeitures (shares)   58,885        
Share-based compensation expense 884     884    
Restricted stock surrendered due to employee tax liability (shares)   (13,604) (13,604)      
Restricted stock surrendered due to employee tax liability (431)   $ (431)      
Cash dividends declared (7,756)         (7,756)
Net income 14,855         14,855
Change in unrealized gain on securities available for sale, net of income taxes (6,321)       (6,321)  
Balance at end of period at Mar. 31, 2018 564,278 $ 33 $ (72,320) 567,081 (8,207) 77,691
Ending balance, shares issued (shares) at Mar. 31, 2018   33,167,768        
Ending balance, treasury stock (shares) at Mar. 31, 2018     (665,110)      
Ending balance, shares outstanding (shares) at Mar. 31, 2018   32,502,658        
Balance at beginning of period at Dec. 31, 2018 $ 552,568 $ 33 $ (108,637) 569,712 (6,079) 97,539
Beginning balance, shares issued (shares) at Dec. 31, 2018   33,202,369        
Beginning balance, treasury stock (shares) at Dec. 31, 2018 (2,273,932)   (2,273,932)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2018   30,928,437        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised $ 8     8    
Restricted stock awards, net of forfeitures (shares)   (49,131)        
Restricted stock awards, net of forfeitures $ 0          
Stock options exercised (shares) 650 650        
Share-based compensation expense $ 712     712    
Restricted stock surrendered due to employee tax liability (shares)   (19,423) (19,423)      
Restricted stock surrendered due to employee tax liability (425)   $ (425)      
Cash dividends declared (7,440)         (7,440)
Net income 14,672         14,672
Change in unrealized gain on securities available for sale, net of income taxes 4,197       4,197  
Balance at end of period at Mar. 31, 2019 $ 564,292 $ 33 $ (109,062) $ 570,432 $ (1,882) $ 104,771
Ending balance, shares issued (shares) at Mar. 31, 2019   33,153,888        
Ending balance, treasury stock (shares) at Mar. 31, 2019 (2,293,355)   (2,293,355)      
Ending balance, shares outstanding (shares) at Mar. 31, 2019   30,860,533